AP406A - Substituted benzenemethanamine derivatives. - Google Patents

Substituted benzenemethanamine derivatives. Download PDF

Info

Publication number
AP406A
AP406A APAP/P/1992/000469A AP9200469A AP406A AP 406 A AP406 A AP 406A AP 9200469 A AP9200469 A AP 9200469A AP 406 A AP406 A AP 406A
Authority
AP
ARIPO
Prior art keywords
formula
hydrogen
halo
radical
compound
Prior art date
Application number
APAP/P/1992/000469A
Other languages
English (en)
Other versions
AP9200469A0 (en
Inventor
Janssen
DAELE Georges Henri Paul VAN (Deceased)
Jean-Paul Rene Marie Andre Bosmans
Den Keybus Frans Maria Alfons Van
Karin Josepha Malvina Maria Nuyens
Paul Adriaan Jan Janssen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AP9200469A0 publication Critical patent/AP9200469A0/xx
Application granted granted Critical
Publication of AP406A publication Critical patent/AP406A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
APAP/P/1992/000469A 1991-12-30 1992-12-29 Substituted benzenemethanamine derivatives. AP406A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91203430 1991-12-30

Publications (2)

Publication Number Publication Date
AP9200469A0 AP9200469A0 (en) 1993-01-31
AP406A true AP406A (en) 1995-09-22

Family

ID=8208118

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000469A AP406A (en) 1991-12-30 1992-12-29 Substituted benzenemethanamine derivatives.

Country Status (17)

Country Link
US (2) US5407961A (enrdf_load_stackoverflow)
EP (1) EP0620809B1 (enrdf_load_stackoverflow)
JP (1) JPH07502524A (enrdf_load_stackoverflow)
CN (1) CN1033451C (enrdf_load_stackoverflow)
AP (1) AP406A (enrdf_load_stackoverflow)
AT (1) ATE149484T1 (enrdf_load_stackoverflow)
AU (1) AU664874B2 (enrdf_load_stackoverflow)
CA (1) CA2125676A1 (enrdf_load_stackoverflow)
DE (1) DE69217992T2 (enrdf_load_stackoverflow)
FI (1) FI943120L (enrdf_load_stackoverflow)
HU (1) HUT67030A (enrdf_load_stackoverflow)
IL (1) IL104258A (enrdf_load_stackoverflow)
MX (1) MX9207620A (enrdf_load_stackoverflow)
NO (1) NO942481D0 (enrdf_load_stackoverflow)
TW (1) TW249227B (enrdf_load_stackoverflow)
WO (1) WO1993013052A1 (enrdf_load_stackoverflow)
ZA (1) ZA9210079B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
AU709303B2 (en) 1994-10-21 1999-08-26 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
DE69722934T2 (de) 1996-05-01 2004-05-27 NPS Pharmaceuticals, Inc., Salt Lake City Verbindungen , die auf anorganische ionen-rezeptoren wirken
DE69932820D1 (de) * 1998-06-19 2006-09-28 Us Health Thiolester und ihre anwendungen
TR200100458T2 (tr) 1998-08-13 2001-07-23 Aventis Cropscience Gmbh Asilleştirilmiş aminofenilsulfonil üreli herbisit ilaçlar
BR0207297A (pt) 2001-02-15 2005-04-19 King Pharmaceuticals Inc Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
EP2280601A4 (en) * 2008-02-21 2012-08-29 Sequoia Pharmaceuticals Inc AMINO ACID HEMMER OF CYTOCHROM P450

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006713A1 (en) * 1978-06-23 1980-01-09 Janssen Pharmaceutica N.V. Novel alpha-amino-phenylacetic acid derivatives, processes for their preparation, their use as herbicidal, algicidal and plant growth regulating agents, and herbicidal, algicidal and plant growth regulating compositions containing them
US4939295A (en) * 1988-07-26 1990-07-03 Zambon Group S.P.A. Process for the preparation of intermediates for the synthesis of diltiazem
WO1992000952A1 (en) * 1990-07-10 1992-01-23 Janssen Pharmaceutica N.V. Hiv-inhibiting benzeneacetamide derivatives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006713A1 (en) * 1978-06-23 1980-01-09 Janssen Pharmaceutica N.V. Novel alpha-amino-phenylacetic acid derivatives, processes for their preparation, their use as herbicidal, algicidal and plant growth regulating agents, and herbicidal, algicidal and plant growth regulating compositions containing them
US4939295A (en) * 1988-07-26 1990-07-03 Zambon Group S.P.A. Process for the preparation of intermediates for the synthesis of diltiazem
WO1992000952A1 (en) * 1990-07-10 1992-01-23 Janssen Pharmaceutica N.V. Hiv-inhibiting benzeneacetamide derivatives

Also Published As

Publication number Publication date
AU3258193A (en) 1993-07-28
EP0620809B1 (en) 1997-03-05
DE69217992T2 (de) 1997-06-12
US5480912A (en) 1996-01-02
WO1993013052A1 (en) 1993-07-08
MX9207620A (es) 1993-06-01
CN1073936A (zh) 1993-07-07
HUT67030A (en) 1995-01-30
IL104258A0 (en) 1993-05-13
IL104258A (en) 1997-04-15
AU664874B2 (en) 1995-12-07
US5407961A (en) 1995-04-18
FI943120A7 (fi) 1994-06-29
CN1033451C (zh) 1996-12-04
FI943120A0 (fi) 1994-06-29
CA2125676A1 (en) 1993-07-08
TW249227B (enrdf_load_stackoverflow) 1995-06-11
JPH07502524A (ja) 1995-03-16
NO942481L (enrdf_load_stackoverflow) 1994-06-30
AP9200469A0 (en) 1993-01-31
FI943120L (fi) 1994-06-29
NO942481D0 (enrdf_load_stackoverflow) 1994-06-30
HU9401381D0 (en) 1994-08-29
EP0620809A1 (en) 1994-10-26
ZA9210079B (en) 1994-06-29
DE69217992D1 (de) 1997-04-10
ATE149484T1 (de) 1997-03-15

Similar Documents

Publication Publication Date Title
AP406A (en) Substituted benzenemethanamine derivatives.
CA2481012C (en) Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US6897224B2 (en) Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
CZ2004634A3 (cs) Chinolinová sloučeninaŹ způsob výroby a použití a farmaceutický přípravek
EP0538301B1 (en) Hiv-inhibiting benzeneacetamide derivatives
NZ546473A (en) 1-amino-2-oxy-substituted tetrahydronaphthalene derivatives, methods for the production thereof, and their use as antiphlogistics
CA2221357A1 (en) Phenyl dihydrobenzofuranes
WO1998007715A9 (en) Novel benzofuran-4-carboxamides
US20090012056A1 (en) Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor
CA2598205A1 (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EP1928833A1 (en) Novel quinoline compounds capable of binding at the cb2 receptor
JP2002517495A (ja) ホスホジエステラーゼ４の阻害剤としてのテトラヒドロフラニルオキシ置換基を有するベンズアミド
US20060229305A1 (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
AP392A (en) Heterocycle-substituted benzylamine derivatives as antiretroviral compounds.
KR20070050469A (ko) 알킬리덴-테트라히드로나프탈렌 유도체, 그 제조 방법 및항염증제로서의 용도
US7332485B2 (en) Peptide deformylase inhibitors
US20060084652A1 (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US5587387A (en) Heterocycle-substituted benzenemethanamine derivatives